Literature DB >> 30388027

Botulinum and Tetanus Neurotoxins.

Min Dong1,2, Geoffrey Masuyer3, Pål Stenmark3,4.   

Abstract

Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) are the most potent toxins known and cause botulism and tetanus, respectively. BoNTs are also widely utilized as therapeutic toxins. They contain three functional domains responsible for receptor-binding, membrane translocation, and proteolytic cleavage of host proteins required for synaptic vesicle exocytosis. These toxins also have distinct features: BoNTs exist within a progenitor toxin complex (PTC), which protects the toxin and facilitates its absorption in the gastrointestinal tract, whereas TeNT is uniquely transported retrogradely within motor neurons. Our increasing knowledge of these toxins has allowed the development of engineered toxins for medical uses. The discovery of new BoNTs and BoNT-like proteins provides additional tools to understand the evolution of the toxins and to engineer toxin-based therapeutics. This review summarizes the progress on our understanding of BoNTs and TeNT, focusing on the PTC, receptor recognition, new BoNT-like toxins, and therapeutic toxin engineering.

Entities:  

Keywords:  bacterial toxin; botulinum neurotoxin; clostridium; protein engineering; tetanus neurotoxin; toxin

Mesh:

Substances:

Year:  2018        PMID: 30388027     DOI: 10.1146/annurev-biochem-013118-111654

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  39 in total

1.  A ribonucleotide reductase from Clostridium botulinum reveals distinct evolutionary pathways to regulation via the overall activity site.

Authors:  Markel Martínez-Carranza; Venkateswara Rao Jonna; Daniel Lundin; Margareta Sahlin; Lars-Anders Carlson; Newal Jemal; Martin Högbom; Britt-Marie Sjöberg; Pål Stenmark; Anders Hofer
Journal:  J Biol Chem       Date:  2020-09-03       Impact factor: 5.157

2.  Botulinum Neurotoxins: Mechanism of Action.

Authors:  O Rossetto; M Pirazzini; F Fabris; C Montecucco
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity.

Authors:  Travis R Blum; Hao Liu; Michael S Packer; Xiaozhe Xiong; Pyung-Gang Lee; Sicai Zhang; Michelle Richter; George Minasov; Karla J F Satchell; Min Dong; David R Liu
Journal:  Science       Date:  2021-02-19       Impact factor: 47.728

Review 4.  Lacrimal gland botulinum toxin injection for epiphora management.

Authors:  Johnathan Jeffers; Katherine Lucarelli; Sruti Akella; Pete Setabutr; Ted H Wojno; Vinay Aakalu
Journal:  Orbit       Date:  2021-08-15

5.  Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in mice.

Authors:  Marco Pirazzini; Alessandro Grinzato; Davide Corti; Sonia Barbieri; Oneda Leka; Francesca Vallese; Marika Tonellato; Chiara Silacci-Fregni; Luca Piccoli; Eaazhisai Kandiah; Giampietro Schiavo; Giuseppe Zanotti; Antonio Lanzavecchia; Cesare Montecucco
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

6.  The Structure and Classification of Botulinum Toxins.

Authors:  Min Dong; Pål Stenmark
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Discovery of Dipeptides as Potent Botulinum Neurotoxin A Light-Chain Inhibitors.

Authors:  Martin Amezcua; Ricardo S Cruz; Alex Ku; Wilfred Moran; Marcos E Ortega; Nicholas T Salzameda
Journal:  ACS Med Chem Lett       Date:  2021-01-27       Impact factor: 4.345

8.  Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.

Authors:  Oneda Leka; Yufan Wu; Xiaodan Li; Richard A Kammerer
Journal:  J Biol Chem       Date:  2021-04-20       Impact factor: 5.157

9.  Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.

Authors:  Takeharu Minamitani; Karin Kiyose; Ryota Otsubo; Toshihiro Ito; Hiroki Akiba; Rika A Furuta; Tsuyoshi Inoue; Kouhei Tsumoto; Masahiro Satake; Teruhito Yasui
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

10.  Recombinant L-HN Fusion Antigen Derived from the L and HN Domains of Botulinum Neurotoxin B Stimulates a Protective Antibody Response Against Active Neurotoxin.

Authors:  Zhen Li; Jian-Sheng Lu; Shan Liu; Rong Wang; Qing Xu; Yun-Zhou Yu; Zhi-Xin Yang
Journal:  Neurotox Res       Date:  2021-02-22       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.